Literature DB >> 27917738

Incidence and factors associated with emergency department visits for recurrent skin and soft tissue infections in patients in California, 2005-2011.

L May1, E Y Klein2, E M Martinez3, N Mojica3, L G Miller4.   

Abstract

More than 2 million visits for skin and soft tissue infections (SSTIs) are seen in US emergency departments (EDs) yearly. Up to 50% of patients with SSTIs, suffer from recurrences, but associated factors remain poorly understood. We performed a retrospective study of patients with primary diagnosis of SSTI between 2005 and 2011 using California ED discharge data from the State Emergency Department Databases and State Inpatient Databases. Using a multivariable logistic regression, we examined factors associated with a repeat SSTI ED visits up to 6 months after the initial SSTI. Among 197 371 SSTIs, 16·3% were associated with a recurrent ED visit. We found no trend in recurrent visits over time (χ 2 trend = 0·68, P = 0·4). Race/ethnicity, age, geographical location, household income, and comorbidities were all associated with recurrent visits. Recurrent ED visits were associated with drug/alcohol abuse or liver disease [odds ratio (OR) 1·4, 95% confidence interval (CI) 1·3-1·4], obesity (OR 1·3, 95% CI 1·2-1·4), and in infections that were drained (OR 1·1, 95% CI 1·1-1·1) and inversely associated with hospitalization after initial ED visit (OR 0·4, 95% CI 0·3-0·4). In conclusion, we found several patient-level factors associated with recurrent ED visits. Identification of these high-risk groups is critical for future ED-based interventions.

Entities:  

Keywords:  Skin and soft tissue

Mesh:

Year:  2016        PMID: 27917738      PMCID: PMC9507778          DOI: 10.1017/S0950268816002855

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  33 in total

1.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

Review 2.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.

Authors:  Nicola Zetola; John S Francis; Eric L Nuermberger; William R Bishai
Journal:  Lancet Infect Dis       Date:  2005-05       Impact factor: 25.071

3.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2014-06-18       Impact factor: 9.079

4.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999.

Authors:  Mary E Stemper; Sanjay K Shukla; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

7.  A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

Authors:  Larissa S May; Richard E Rothman; Loren G Miller; Gillian Brooks; Mark Zocchi; Catherine Zatorski; Andrea F Dugas; Chelsea E Ware; Jeanne A Jordan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-08-26       Impact factor: 3.254

8.  A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.

Authors:  David A Talan; Frank Lovecchio; Fredrick M Abrahamian; David J Karras; Mark T Steele; Richard E Rothman; Anusha Krishnadasan; William R Mower; Rebecca Hoagland; Gregory J Moran
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

9.  Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients.

Authors:  G N Delorenze; M A Horberg; M J Silverberg; A Tsai; C P Quesenberry; R Baxter
Journal:  Epidemiol Infect       Date:  2013-02-18       Impact factor: 4.434

10.  Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010.

Authors:  Loren G Miller; Debra F Eisenberg; Honghu Liu; Chun-Lan Chang; Yan Wang; Rakesh Luthra; Anna Wallace; Christy Fang; Joseph Singer; Jose A Suaya
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

View more
  4 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.

Authors:  Lauren K Whiteside; Ly Huynh; Sophie Morse; Jane Hall; William Meurer; Caleb J Banta-Green; Hannah Scheuer; Rebecca Cunningham; Mark McGovern; Douglas F Zatzick
Journal:  J Subst Abuse Treat       Date:  2021-11-24

3.  National Costs Associated With Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.

Authors:  Eili Y Klein; Wendi Jiang; Nestor Mojica; Katie K Tseng; Ryan McNeill; Sara E Cosgrove; Trish M Perl
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

4.  Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid.

Authors:  Frederick Wittke; Catherine Vincent; James Chen; Barry Heller; Heidi Kabler; J Scott Overcash; François Leylavergne; Guennaëlle Dieppois
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.